about
Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for eliminationAuthors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic reviewMatrix metalloproteinases in tuberculosis.Diagnostic accuracy of nucleic acid amplification tests (NAATs) in urine for genitourinary tuberculosis: a systematic review and meta-analysis.Multidrug resistant tuberculosis.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.MMP-1 drives immunopathology in human tuberculosis and transgenic mice.Association of major depressive episode with negative outcomes of tuberculosis treatmentKnowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study.HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study.Induced sputum is safe and well-tolerated for TB diagnosis in a resource-poor primary healthcare settingClinical management of concurrent diabetes and tuberculosis and the implications for patient servicesNeutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary TuberculosisMicroscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug ResistanceAn Outbreak of Bartonella bacilliformis in an Endemic Andean Community.Private sector contributions and their effect on physician emigration in the developing world.Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.[Knowledge, attitudes, and practices about Carrión's disease in rural Ancash, Peru].Acerca de "Mapeo político de la discriminación y homofobia asociadas con la epidemia de VIH en México".Diseases masking and delaying the diagnosis of urogenital tuberculosis.Interventions for the prevention of risk factors and incidence of type 2 diabetes in the work environment: a systematic reviewLatent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritisAssociation between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysisIs diabetes associated with malaria and malaria severity? A systematic review of observational studiesIs there an association between cutaneous leishmaniasis and skin cancer? A systematic review
P50
Q21144773-53AD14E9-94C8-4B02-A745-326FE0DE7719Q26996522-79356E3C-53EA-4731-8FF8-494B9242FFBBQ30403630-3092E2DC-6962-449F-9B5C-6DD95F7D2294Q33767720-EB24EB5A-5F85-4079-824E-BFF14BF706A6Q34464757-32CBADFD-0384-4A4A-BD4F-ABD3DBBF4326Q34479280-5F846881-37D4-41EF-A539-B0A6BE8FC98FQ34684277-913CC219-B62A-4A22-B935-6D5D129A0348Q34876365-EF0E4881-DF8D-40C9-8A4F-533CF4A41943Q34902852-1ECBE075-90FC-492C-9BBE-3014E268FE2AQ35077011-B4FC4957-15BD-4A41-B18F-8B0A7DA10CB1Q35130640-41B334FD-800C-4C96-A0C8-6FE568DB90CFQ35150367-1BBE267C-9DC2-45ED-8FA3-769858690C8AQ35240921-65D8D092-A5C1-4261-9A23-DE7CB139798FQ35634195-2CEAFFB5-DACB-43A0-9706-89EAC18ACD02Q35825295-194B1653-5EAF-4017-BF0A-98D1851CC570Q35962743-8C5CA070-CD6E-4AE0-B860-2B32317AD2C3Q36663475-9EABCFF2-9DC8-4FCE-A72C-288B2D17FCFBQ39363118-2AEBD871-6FA3-4A2A-920E-1498595F61DBQ45105426-C6E181D5-1471-4091-9C7D-2B58AA770005Q53782548-BDDFAA3B-745B-4DCC-947C-22064A665856Q55003969-EE1829FB-A12A-4271-B076-CA71B923C510Q91690525-CF01F508-E19C-4B63-A2B5-89C52D26CC49Q91892628-2065D759-9E6B-4D80-A905-BA87BE038D3EQ92553747-A5DAE6BC-83E5-4608-BB46-2F0E0D60EA59Q92902199-D4813722-D91E-4927-90D8-66EFFFC4B1AAQ93137544-5B9AB8EA-30F5-4E3F-908B-B95FF576F89B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cesar A Ugarte-Gil
@ast
Cesar A Ugarte-Gil
@en
Cesar A Ugarte-Gil
@es
Cesar A Ugarte-Gil
@nl
type
label
Cesar A Ugarte-Gil
@ast
Cesar A Ugarte-Gil
@en
Cesar A Ugarte-Gil
@es
Cesar A Ugarte-Gil
@nl
prefLabel
Cesar A Ugarte-Gil
@ast
Cesar A Ugarte-Gil
@en
Cesar A Ugarte-Gil
@es
Cesar A Ugarte-Gil
@nl
P106
P1153
35194626400
P31
P496
0000-0002-2833-9087